NO20044502L - Analgesisk oral sammensetning med kontrollert frigjoring av et opioid - Google Patents

Analgesisk oral sammensetning med kontrollert frigjoring av et opioid

Info

Publication number
NO20044502L
NO20044502L NO20044502A NO20044502A NO20044502L NO 20044502 L NO20044502 L NO 20044502L NO 20044502 A NO20044502 A NO 20044502A NO 20044502 A NO20044502 A NO 20044502A NO 20044502 L NO20044502 L NO 20044502L
Authority
NO
Norway
Prior art keywords
controlled release
opioid
oral composition
vinylpyrrolide
ester
Prior art date
Application number
NO20044502A
Other languages
English (en)
Norwegian (no)
Inventor
L Uboslav Razus
Ondrej Gattnar
Ivan Varga
Mikulas Lehocky
Viera Kormanova
Viera Hubinova
Original Assignee
Zentiva As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva As filed Critical Zentiva As
Publication of NO20044502L publication Critical patent/NO20044502L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
NO20044502A 2002-04-12 2004-10-21 Analgesisk oral sammensetning med kontrollert frigjoring av et opioid NO20044502L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SK501-2002A SK286107B6 (sk) 2002-04-12 2002-04-12 Analgeticky účinný perorálny liečivý prípravok s kontrolovaným uvoľňovaním opioidnej účinnej látky a spôsob jeho prípravy
PCT/SK2003/000008 WO2003086365A1 (en) 2002-04-12 2003-04-10 Analgesical oral composition with controlled release of an opioid

Publications (1)

Publication Number Publication Date
NO20044502L true NO20044502L (no) 2004-10-26

Family

ID=29247067

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20044502A NO20044502L (no) 2002-04-12 2004-10-21 Analgesisk oral sammensetning med kontrollert frigjoring av et opioid

Country Status (13)

Country Link
EP (1) EP1494656B1 (pl)
AT (1) ATE398446T1 (pl)
AU (1) AU2003219641A1 (pl)
CZ (1) CZ20041054A3 (pl)
DE (1) DE60321672D1 (pl)
EA (1) EA006846B1 (pl)
GE (1) GEP20063991B (pl)
HU (1) HUP0500438A3 (pl)
NO (1) NO20044502L (pl)
PL (1) PL372698A1 (pl)
SK (1) SK286107B6 (pl)
UA (1) UA74991C2 (pl)
WO (1) WO2003086365A1 (pl)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3750145T2 (de) * 1986-06-10 1994-11-03 Euro Celtique Sa Zusammensetzung mit kontrollierter Freisetzung von Dihydrocodein.
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
DE19747261A1 (de) * 1997-10-25 1999-04-29 Bayer Ag Osmotisches Arzneimittelfreisetzungssystem
KR100889069B1 (ko) * 1999-10-29 2009-03-17 유로-셀티크 소시에떼 아노뉨 서방성 하이드로코돈 제형
SK285128B6 (sk) * 1999-12-28 2006-07-07 Zentiva, A. S. Liečivý prípravok s riadeným uvoľňovaním obsahujúci tramadol hydrochlorid a spôsob jeho prípravy

Also Published As

Publication number Publication date
ATE398446T1 (de) 2008-07-15
SK286107B6 (sk) 2008-03-05
EA200401357A1 (ru) 2005-04-28
EP1494656A1 (en) 2005-01-12
UA74991C2 (en) 2006-02-15
SK5012002A3 (en) 2003-11-04
AU2003219641A1 (en) 2003-10-27
CZ20041054A3 (cs) 2005-01-12
PL372698A1 (pl) 2005-07-25
HUP0500438A2 (hu) 2005-08-29
HUP0500438A3 (en) 2008-03-28
WO2003086365A1 (en) 2003-10-23
EP1494656B1 (en) 2008-06-18
DE60321672D1 (de) 2008-07-31
GEP20063991B (en) 2006-12-11
EA006846B1 (ru) 2006-04-28

Similar Documents

Publication Publication Date Title
CA2582150C (en) Modified release ibuprofen dosage form
NO20065638L (no) Formuleringer med kontrollert frigivelse inneholdende vardenafil
NO20080827L (no) Faste doseringsformuleringer av narkotiske legemidler som har forbedret bukal adsorpsjon
ES2642788T3 (es) Fabricación de gránulos sin principio activo y de comprimidos que comprenden los mismos
JO2555B1 (en) Forms of oral doses of propiferine or pharmaceutically acceptable salts thereof with an extended release of active agent
BRPI0608505A2 (pt) comprimido sublingual revestido
CA2503361A1 (en) Controlled-release compositions
CN100594936C (zh) 改善透粘膜给药制剂的吸收的方法
US20090214442A1 (en) Oral Transmucosal Nicotine Dosage Form
BR112020003380A2 (pt) formulações farmacêuticas para o tratamento de endometriose, miomas uterinos, síndrome do ovário policístico ou adenomiose
JP2008013542A (ja) 去痰又は気道杯細胞過形成抑制のための医薬組成物
AP2003002763A0 (en) Controlled release formulations for oral administration
US8999384B2 (en) Immediate release compositions of acid labile drugs
AU2018285927B2 (en) Modified-release tiopronin compositions, kits and methods for treating cystinuria and related disorders
WO2005065664A8 (en) Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent
TWI589292B (zh) 用於控管噁心及嘔吐之組合物
NO20044502L (no) Analgesisk oral sammensetning med kontrollert frigjoring av et opioid
ES2989170T3 (es) Métodos no hormonales para la anticoncepción masculina que comprenden (R)-silodosina
WO2000026185A3 (en) Omeprazole solution and method of using same
JP7366108B2 (ja) ロキソプロフェン又はその塩及びビタミンｂ１２類を含有する経口用医薬組成物
BRPI0506710A (pt) composições farmacêuticas de liberação controlada
EP2848260B1 (en) Novel formulations of thiocolchicoside
US20230285369A1 (en) Use of gaboxadol for the treatment of non-24 hour sleep-wake disorder
WO2011067663A1 (en) Pharmaceutical preparations comprising phloroglucinol and/or derivatives thereof and some non-steroidal anti-inflammatory drugs and their use in the treatment and/or prevention of pain syndromes of the feminine genital system
HK40045537B (en) Immediate release dosage form

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application